Clinical Trials Logo

Depression clinical trials

View clinical trials related to Depression.

Filter by:

NCT ID: NCT05634265 Completed - Depression Clinical Trials

Social Media for ART Adherence and Retention in Adolescents and Young Adults: the Vijana-SMART Study

Start date: January 31, 2019
Phase: N/A
Study type: Interventional

The goal of this study is to investigate whether a virtual peer support group improves ART knowledge, adherence, and mental health in youth living with HIV in Kenya.

NCT ID: NCT05633368 Completed - Covid-19 Clinical Trials

Impact of Covid-19 Pandemic on Patients Receiving Continuation or Maintenance Electroconvulsive Therapy

COVID-M-ECT
Start date: March 31, 2020
Phase:
Study type: Observational

Electroconvulsive therapy is a safe and effective therapeutic strategy in patients with treatment resistant depression. As relapse after successful ECT is significant even with adequate pharmacological strategies, continuation (up to 6 months after completion of index-ECT) or maintenance ECT (more than 6 months after index-ECT) is often necessary to maintain remission. During the current Covid-19 pandemic hospitals redirected resources and closed or significantly diminished ECT services. In this study we aim to assess the impact of discontinuing maintenance electroconvulsive therapy in patients diagnosed with unipolar depressive disorder.

NCT ID: NCT05633186 Completed - Depression Clinical Trials

Sustainable Upscaling of Depression Prevention

Start date: August 31, 2022
Phase: N/A
Study type: Interventional

Research shows that online unguided self-help interventions focused on psycho-education, skills training and lifestyle can prevent mild mood complaints from turning into a full-blown depression. These encouraging results are found even though the adherence to these types of interventions is generally low. With this project, the investigators examine whether effectiveness and adherence to online unguided self-help interventions can be increased by additional motivational guidance elements. This is examined by adding three additional components to the intervention: 1) A coach who provides online feedback once a week to provide support. 2) Mobile application to monitor mood and related factors and to receive automated personalized messages, 3) Content based on the principles of motivational interviewing. A secondary aim is to compare the additional effects of the individual components against the additional costs.

NCT ID: NCT05631145 Completed - Depression, Anxiety Clinical Trials

MT Combined With XKSA for Depressive Symptoms During COVID-19

Start date: May 3, 2020
Phase: N/A
Study type: Interventional

Social isolation related mental health problems have raised many concerns during the COVID-19 outbreaks. Mental health care for people in quarantined hotels is in urgent need, but concrete program is rarely reported. Morita therapy and acupressure have been identified as effective treatments for regulating mood and sleep. The study aimed to examine whether Morita therapy (MT) combined with Xingnao Kaiqiao self-administered acupressure (XKSA) could improve depressive, anxiety symptoms and sleep quality in isolated people with depressive symptoms.

NCT ID: NCT05628675 Completed - Depression Clinical Trials

A Prenatal Bonding Intervention for Pregnant Women With Depression

Start date: November 17, 2022
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to test a group for pregnant women with depression that aims to help them build a stronger relationship with their unborn baby. The main questions it aims to answer are: - Is the group acceptable to pregnant women with depression? - Is it possible to run this group with pregnant women with depression? Participants will be asked to: - attend the group (which lasts 90mins) - complete questionnaires before and after the group, and 1 month later

NCT ID: NCT05627206 Completed - Anxiety Clinical Trials

The Impact of PM+For Moms Intervention on Improving Mother's Mental Health in Zambia (PM+FM)

PM+FM
Start date: November 15, 2022
Phase: N/A
Study type: Interventional

CMHD are particularly prevalent among women, posing a major threat to their own and their children's wellbeing. Despite the high prevalence of CMHD and the existence of effective treatments, interventions supporting women living in low-resourced settings remain limited. This study builds on a parent study (Zamcharts NCT03991182), which identified a high prevalence of women with anxiety and/or depression. We propose to design, test, and validate a community-based intervention nested within the public primary health system in Zambia, to identify and treat women with mild-to-severe CMHDs.

NCT ID: NCT05627154 Completed - Depression Clinical Trials

Combined Antidepressant and Behavioural Intervention

CABIN
Start date: May 28, 2021
Phase: N/A
Study type: Interventional

A body of evidence from both animal and human research suggests that antidepressant drugs may induce early changes in emotional processing that interact with environmental factors to produce a later change in mood. This experimental medicine study will examine the effect of citalopram on emotional cognition under different environmental conditions (as manipulated by the presence or absence of behavioural activation training). Participants will be administered either citalopram or placebo over the course of two weeks. Citalopram will be taken either alone or in combination with behavioural activation training.

NCT ID: NCT05617300 Completed - Dementia Clinical Trials

Mindfulness-based Dementia Care Partner Program to Reduce Depressive Symptoms

Start date: November 7, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the feasibility, acceptability, and fidelity of implementation of the Mindfulness Based Dementia Care (MBDC) program to reduce depressive symptoms in care partners (CPs) of people living with dementia (PLWD).

NCT ID: NCT05615948 Completed - Clinical trials for Major Depressive Disorder

Oral Aspirin + Ketamine as Adjunct to Oral Antidepressant Therapy for Depression

Start date: December 6, 2022
Phase: Phase 4
Study type: Interventional

The purpose of this study is to assess the effects of simultaneous administration of oral aspirin and oral ketamine as a therapeutic for those with Treatment Resistant Depression.

NCT ID: NCT05606601 Completed - Depression Clinical Trials

An Online Intervention Addressing Mental Health and Substance Use in University Students

Start date: September 28, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the effectiveness of mobile app containing a range of evidence based tools to improve the mental health and substance use outcomes of university students.